HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage.

Abstract
Low-dose (7 mg/kg per day) disopyramide administration to arrhythmic chagasic patients decreased the frequency of ventricular extrasystoles in 4 of 17 patients (24%) and suppressed most complex ventricular arrhythmias in 12 of 15 patients (80%). This assessment was made from 72-h continuous Holter monitoring recorded during the course of this double blind, placebo-controlled randomized crossover study. Seven patients (41%) complained of anticholinergic side effects, but no contractile or conduction system depression was seen. Amiodarone (200 mg) given on a single blind, placebo-controlled basis to 9 of these patients reduced the frequency of ventricular extrasystoles in 6 of 9 patients (67%) and suppressed complex ventricular ectopy in 6 of 7 patients (85%). One patient was unable to tolerate this drug (11%). Both drugs seemed less effective in controlling supraventricular arrhythmias, although disopyramide eliminated paroxysms of supraventricular tachycardia in 9 of 13 (69%) and amiodarone in all 6 patients with this arrhythmia. Amiodarone appears to be a better antiarrhythmic drug for chagasic patients, due to its greater effectiveness and lower incidence of side effects.
AuthorsH A Carrasco, A V Vicuña, C Molina, A Landaeta, J Reynosa, N Vicuña, A Fuenmayor, F López
JournalInternational journal of cardiology (Int J Cardiol) Vol. 9 Issue 4 Pg. 425-38 (Dec 1985) ISSN: 0167-5273 [Print] Netherlands
PMID3908329 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Benzofurans
  • Disopyramide
  • Amiodarone
Topics
  • Administration, Oral
  • Adult
  • Aged
  • Amiodarone (administration & dosage, therapeutic use)
  • Arrhythmias, Cardiac (drug therapy, etiology)
  • Benzofurans (therapeutic use)
  • Chagas Cardiomyopathy (complications)
  • Clinical Trials as Topic
  • Disopyramide (administration & dosage, therapeutic use)
  • Double-Blind Method
  • Female
  • Heart Atria (physiopathology)
  • Heart Ventricles (physiopathology)
  • Humans
  • Male
  • Middle Aged
  • Myocardium (pathology)
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: